NEW YORK, July 27, 2017 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Ocular Therapeutix, Inc. ("Ocular Therapeutix") (NASDAQ:OCUL) between May 5, 2017 and July 6, 2017. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the District of New Jersey. To get more information go to:
http://www.zlk.com/pslra-sba/ocular-therapeutix-inc?wire=3
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Ocular Therapeutix's management has been misleading investors about DEXTENZA manufacturing issues, including that more than 50% of lots manufactured by Ocular Therapeutix contain bad product; (2) such manufacturing issues could impact the approval of DEXTENZA by the FDA; and (3) as a result, defendants’ public statements were materially false and misleading.
If you suffered a loss in Ocular Therapeutix you have until September 5, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


First Western Ship Transits Strait of Hormuz Since Iran War Began
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
Apple Turns 50: From Garage Startup to AI Crossroads
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push 



